These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9157781)

  • 21. Tumor cells are the source of osteopontin and bone sialoprotein expression in human breast cancer.
    Sharp JA; Sung V; Slavin J; Thompson EW; Henderson MA
    Lab Invest; 1999 Jul; 79(7):869-77. PubMed ID: 10418827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
    Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
    Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis.
    D'Andrea MR; Limiti MR; Bari M; Zambenedetti P; Montagutti A; Ricci F; Pappagallo GL; Sartori D; Vinante O; Mingazzini PL
    Breast Cancer Res Treat; 2007 Mar; 101(3):279-84. PubMed ID: 16835704
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of chemotherapy on status of estrogen receptors in primary tumors and lymph node metastases of human ductal breast cancer.
    Koda M; Lenczewski A; Sulkowska M; Kanczuga-Koda L; Wincewicz A; Tomaszewski J; Sulkowski S
    Oncol Rep; 2007 Feb; 17(2):385-91. PubMed ID: 17203178
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of bone sialoprotein in primary human breast cancer is associated with poor survival.
    Bellahcène A; Menard S; Bufalino R; Moreau L; Castronovo V
    Int J Cancer; 1996 Aug; 69(4):350-3. PubMed ID: 8797881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bone sialoprotein is predictive of bone metastases in resectable non-small-cell lung cancer: a retrospective case-control study.
    Papotti M; Kalebic T; Volante M; Chiusa L; Bacillo E; Cappia S; Lausi P; Novello S; Borasio P; Scagliotti GV
    J Clin Oncol; 2006 Oct; 24(30):4818-24. PubMed ID: 17050866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of chemotherapy on Ki-67, Bcl-2 and Bak expression in primary tumors and lymph node metastases of breast cancer.
    Koda M; Sulkowska M; Kanczuga-Koda L; Tomaszewski J; Kucharczuk W; Lesniewicz T; Cymek S; Sulkowski S
    Oncol Rep; 2007 Jul; 18(1):113-9. PubMed ID: 17549355
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.
    Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ
    J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical significance of hMAM mRNA detection in bone marrow of breast carcinoma patient].
    Li BJ; Wang JY; Wang HY; Huang XP; Zhang LJ; Long H; Yang MT; Rong TH
    Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):766-9. PubMed ID: 17366790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective or routine axillary disease staging for patients with clinically lymph node-negative breast cancer?
    Hieken TJ; Velasco JM
    Surgery; 2006 Oct; 140(4):500-7; discussion 507-8. PubMed ID: 17011896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered expression of metastasis-associated and regulatory molecules in effusions from breast cancer patients: a novel model for tumor progression.
    Davidson B; Konstantinovsky S; Nielsen S; Dong HP; Berner A; Vyberg M; Reich R
    Clin Cancer Res; 2004 Nov; 10(21):7335-46. PubMed ID: 15534110
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative analysis of bone marrow micrometastases with sentinel lymph node status in early-stage breast cancer.
    Saha S; Ali S; Ghanem M; Soni M; Wiese D; Arora M; Singh T; Iddings D
    Ann Surg Oncol; 2009 Feb; 16(2):276-80. PubMed ID: 19050967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bone morphogenetic proteins secreted by breast cancer cells upregulate bone sialoprotein expression in preosteoblast cells.
    Bunyaratavej P; Hullinger TG; Somerman MJ
    Exp Cell Res; 2000 Nov; 260(2):324-33. PubMed ID: 11035927
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced nuclear expression of transcription factor AP-2 associates with aggressive breast cancer.
    Pellikainen J; Kataja V; Ropponen K; Kellokoski J; Pietiläinen T; Böhm J; Eskelinen M; Kosma VM
    Clin Cancer Res; 2002 Nov; 8(11):3487-95. PubMed ID: 12429639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survival of patients with metastatic breast carcinoma: importance of prognostic markers of the primary tumor.
    Chang J; Clark GM; Allred DC; Mohsin S; Chamness G; Elledge RM
    Cancer; 2003 Feb; 97(3):545-53. PubMed ID: 12548595
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High levels of messenger RNAs for tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in primary breast carcinomas are associated with development of distant metastases.
    Ree AH; Florenes VA; Berg JP; Maelandsmo GM; Nesland JM; Fodstad O
    Clin Cancer Res; 1997 Sep; 3(9):1623-8. PubMed ID: 9815852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of E-cadherin in human ductal breast cancer carcinoma in situ, invasive carcinomas, their lymph node metastases, their distant metastases, carcinomas with recurrence and in recurrence.
    Jeschke U; Mylonas I; Kuhn C; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
    Anticancer Res; 2007; 27(4A):1969-74. PubMed ID: 17649807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Osteoblast-related transcription factors Runx2 (Cbfa1/AML3) and MSX2 mediate the expression of bone sialoprotein in human metastatic breast cancer cells.
    Barnes GL; Javed A; Waller SM; Kamal MH; Hebert KE; Hassan MQ; Bellahcene A; Van Wijnen AJ; Young MF; Lian JB; Stein GS; Gerstenfeld LC
    Cancer Res; 2003 May; 63(10):2631-7. PubMed ID: 12750290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential expression of osteopontin and bone sialoprotein in bone metastasis of breast and prostate carcinoma.
    Carlinfante G; Vassiliou D; Svensson O; Wendel M; Heinegård D; Andersson G
    Clin Exp Metastasis; 2003; 20(5):437-44. PubMed ID: 14524533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of bone sialoprotein in human lung cancer.
    Bellahcène A; Maloujahmoum N; Fisher LW; Pastorino H; Tagliabue E; Ménard S; Castronovo V
    Calcif Tissue Int; 1997 Sep; 61(3):183-8. PubMed ID: 9262507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.